Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip arthroplasty: pooled analysis of coagulation biomarkers and primary efficacy and safety endpoints from two phase 3 trials
Crossref DOI link: https://doi.org/10.1186/s12959-016-0121-1
Published Online: 2016-12-01
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kawai, Yohko
Fuji, Takeshi
Fujita, Satoru
Kimura, Tetsuya
Ibusuki, Kei
Abe, Kenji
Tachibana, Shintaro
Funding for this research was provided by:
Daiichi Sankyo Company
